Navigation Links
ProMetic signs $35 M Long-term Supply Agreement with European Biopharmaceutical company
Date:12/9/2008

CAMBRIDGE, United Kingdom and MONTREAL, Dec. 9 /PRNewswire-FirstCall/ - ProMetic Life Sciences Inc. (TSX:PLI) ("ProMetic") announces that its U.K.-based subsidiary, ProMetic BioSciences Ltd ("PBL"), has signed a Long-term Supply Agreement (the "Agreement") with a world-leading European Biopharmaceutical company estimated to be worth up to $35 M over the next six years, with first shipment delivery starting this quarter. This Agreement will provide access to one of ProMetic's proprietary affinity adsorbents for incorporation into this company's manufacturing process.

"This agreement provides further evidence of the underlying growth in the demand for ProMetic's proprietary affinity adsorbents," commented Dr. Steve Burton, PBL's Chief Executive Officer. Dr. Burton added: "Due to reasons of client confidentiality the terms of the Agreement and the name of ProMetic's partner remain undisclosed."

"More and more biopharmaceutical products that have received or are expecting to receive approval from the regulatory agencies such as the Food and Drug Administration or the European Medicines Agency are now manufactured using ProMetic's affinity adsorbent products," stated Mr. Pierre Laurin, ProMetic's President and Chief Executive Officer. "ProMetic's affinity adsorbent products are therefore locked into the regulated manufacturing processes of these biopharmaceuticals and represent long-term recurring and growing annuity revenues for the Company," concluded Mr. Laurin.

About ProMetic BioSciences Ltd

Using its unique and proprietary Mimetic Ligand(TM) technology, ProMetic BioSciences Ltd ("PBL") specializes in the development and manufacture of robust affinity separation materials which provide very high levels of purification. This is achieved by use of small chemical affinity ligands designed to bind a target biomolecule specifically and reversibly. In view of their use for the production of therapeutics, ProM
'/>"/>

SOURCE Prometic Life Sciences Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. ProMetic to present at Merriman Curhan Fords Investor Summit 2008 on September 16th
2. Prometic reaches understanding for commercialisation of several biopharmaceutical products and strategic investment
3. ProMetic Further Confirms Performance of Prion Capture Resin at the Recovery of Biological Products Conference
4. ProMetic announces Octapharma publication of PRDTS prion removal resin in Octaplas(R) manufacturing process at 30th International Congress of the International Society for Blood Transfusion meeting in Macao SAR, China
5. Prometic provides information for its Annual and Special Meeting of Shareholders
6. ProMetic presents preclinical data for prostate and pancreatic cancer at the AACR Meeting
7. ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc.
8. Prometic to present at the American Chemical Society
9. ProMetic and Sartorius Stedim Biotech collaborate on technology transfer deals in Asia
10. ProMetic reports continued positive data in PBI-1402 phase II trial in chemotherapy-induced anemia
11. ProMetic announces signature of definitive license agreement with Kedrion for two hyperimmune products

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... A mechanised blue dye test alternative ...quality assurance one step closer for pharma-compa...esting machine developed by Sepha for use with ... several local and global pharma-companies such as...y assurance and productivity improvements on the p...
(Date:11/25/2009)... BOSTON, Nov. 25 Biotech firm Repl...omic data from the 1918 pandemic through the predi...pandemic, today issued its latest biochemical anal...hality of the H1N1 ("Swine Flu") virus has dropped...s current outbreak in the spring of 2009 to restin...
(Date:11/25/2009)...AM, ON, Nov. 25 /PRNewswire/ - Cytochroma today an... Board of Directors. Dr. Moldt will replace Mr. Ul...mpany,s Board. The number of Board members remains...sed to welcome Peter Moldt to the board and look f...nce as Cytochroma continues to make progress in be...
(Date:11/25/2009)...DIEGO, Nov. 25 Ardea Bio...at Barry D. Quart, Pharm.D., president and chief e...y 21st Annual Health Care Conference. , ,Presenta...nnual Health Care Conference,Date: Tuesday, D...Location: The New York Palace Hotel, New York, NY...
Breaking Biology Technology:Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 3Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2
... Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ) a... a corporate overview at the upcoming Deutsche Ban...009 at 8:40 a.m. ET at the Intercontinental Hotel,... company presentation can be accessed under "Calen...www.idenix.com . Please log in approximately 5-1...
...Y, MAY 18, 2009 , , SAN DIEGO, May 11 Neurocrin...day that Kevin Gorman, President and Chief Executi...nting at the Deutsche Bank 34th Annual Health Care... takes place Monday, May 18, 2009 at 5:05 p.m. Eas...resentation will be simultaneously webcast and may...
... Neurologists to Plan Next Clinical Studies , , O... (OTC Bulletin Board: TBIO) and Power3 Medical Pro...the clinical introduction of the NuroPro(R) AD and...,s disease at the 2009 American Academy of Neurolo...clinicians distinguish patients with Alzheimer,s a...
Other Biology Technology:Neurocrine Biosciences to Present at the Deutsche Bank 34th Annual Health Care Conference 2Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimer's and Parkinson's Diseases at AAN Annual Meeting 2Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimer's and Parkinson's Diseases at AAN Annual Meeting 3Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimer's and Parkinson's Diseases at AAN Annual Meeting 4Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimer's and Parkinson's Diseases at AAN Annual Meeting 5
(Date:11/26/2009)...26, 2009) Whitehead researchers have developed a ...oint specific genes and proteins used by pathogens...st human cell cultures genes are present in two co...he mother. Gene inactivation by mutation is theref...ed, the second copy usually remains active and tak...
(Date:11/25/2009)... have easy lives. In addition to mammalian immune ...nemies called bacteriophages, viruses that kill ha...l, bacteria and another class of microorganisms ca...ents such as deep-sea volcanic vents) manage just ...-in defense system that helps protect them from ma...
(Date:11/25/2009)...ssistant professors recently received funding from... research beneficial to understanding the environm...her Blackwood, assistant professor in the Departme...upport two separate research projects. , His fir...ommunities and Functions from the Leaf to the Land...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Kent State University professors focus research on the environment with grants totaling $890,000 2Bayer CropScience Announces Investment of 2425 Million for Institute Site 13702 1Bayer CropScience Announces Investment of 2425 Million for Institute Site 13702 2Alexza Stockholders Approve Share Issuance to Symphony Capital and Alexza Completes Acquisition of Symphony Allegro 13698 1Alexza Stockholders Approve Share Issuance to Symphony Capital and Alexza Completes Acquisition of Symphony Allegro 13698 2Alexza Stockholders Approve Share Issuance to Symphony Capital and Alexza Completes Acquisition of Symphony Allegro 13698 3Alexza Stockholders Approve Share Issuance to Symphony Capital and Alexza Completes Acquisition of Symphony Allegro 13698 4Gene Fix in Egg Prevents Inherited Diseases in Monkeys 55432 1Gene Fix in Egg Prevents Inherited Diseases in Monkeys 55432 2Gene Fix in Egg Prevents Inherited Diseases in Monkeys 55432 3
... is available in Spanish . , Contributing to t...e use of an only or a few species); using examples...ies and promoting the participation of experts in ...ommendations town councils should consider when de...at is the opinion of Paloma Carianos Gonzlez , re...
... 2008 -- Underwater wi-fi, music over the internet...hales find their favorite salmon, detecting danger...ryngectomy, rhythm and movement disorders, visuali... a possible way to save manatees from collisions w...will be covered at the 156th meeting of the Acoust...
...t time, scientists have decoded the complete DNA o...myelogenous leukemia - to its genetic roots. A lar...nd the Siteman Cancer Center at Washington Univers...genome of the patient - a woman in her 50s who ult...r leukemia cells, to identify genetic changes uniq...
Other Biology News:Expert recommends town councils to design low-allergy impact green spaces 2Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 2Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 3Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 4Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 5Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 6Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 7Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 8Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 9Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 10Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 11Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 12Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 13Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 14Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 15Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 16Washington University scientists first to sequence genome of cancer patient 2Washington University scientists first to sequence genome of cancer patient 3Washington University scientists first to sequence genome of cancer patient 4Washington University scientists first to sequence genome of cancer patient 5
...es optimized reagents and protocols for the rapid ...rtion of group II introns. The method exploits the...zes a simple PCR step to re-target the TargeTron g...t genome. Utility of the technology has been demon...
Mouse Anti-Human PPIL2 Monoclonal Antibody, Unconjugated, Clone 2E11 from Abnova Corporation
Mouse Anti-Human QARS Monoclonal Antibody, Unconjugated, Clone 5F5 from Abnova Corporation
Mouse Anti-IFNA2 Monoclonal Antibody, Unconjugated, Clone 1F11 from Abnova Corporation
Biology Products: